- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies
U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies
UPDATED Apr 30, 2024
Companies with a Value score of at least 3, ordered by Value score
461 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MKGA.F | €161.00 | 0.3% | -9.8% | €64.8b | €196.72 | PE22.9x | E9.9% | 1.5% | ||
AMPH | US$41.25 | 0.8% | 11.6% | US$2.0b | US$62.60 | PE14.7x | E19.0% | n/a | ||
KNSA | US$18.72 | 5.9% | 48.7% | US$1.3b | US$29.20 | PE153.5x | E55.8% | n/a | ||
UTHR | US$234.33 | -0.06% | 2.4% | US$11.2b | US$288.02 | PE11.2x | E7.5% | n/a | ||
JNJ | US$144.59 | -3.3% | -12.4% | US$348.4b | US$173.60 | PE18.2x | E5.1% | 3.4% | ||
EXAS | US$59.35 | -6.6% | -5.9% | US$10.9b | US$89.37 | PS4.4x | E61.9% | n/a | ||
SPPI | US$1.03 | 5.3% | 17.0% | US$209.9m | US$1.26 | PS8.2x | E67.3% | n/a | ||
INSM | US$24.72 | -2.2% | 28.4% | US$3.7b | US$44.13 | PS12x | E39.2% | n/a | ||
AKYA | US$3.82 | 0.3% | -46.1% | US$190.6m | US$9.00 | PS2x | E55.3% | n/a | ||
OCUP | US$1.59 | 2.9% | -71.3% | US$39.3m | US$19.50 | PS2.1x | E9.5% | n/a | ||
SUPN | US$30.10 | 0.5% | -19.3% | US$1.7b | US$40.33 | PE1257.4x | E58.3% | n/a | ||
ELAN | US$13.16 | -2.2% | 45.1% | US$6.5b | US$17.76 | PS1.5x | E89.1% | n/a | ||
BIO | US$269.75 | -5.4% | -40.3% | US$7.7b | US$419.90 | PS2.9x | E81.3% | n/a | ||
FOLD | US$10.25 | -5.3% | -13.9% | US$3.0b | US$18.78 | PS7.6x | E55.6% | n/a | ||
JUSH.F | US$0.87 | 28.6% | 70.6% | US$129.8m | US$1.08 | PE-2.6x | S6.1% | n/a | ||
INDV | UK£17.56 | -5.7% | -7.6% | UK£2.0b | UK£30.20 | PE488x | E34.7% | 0% | ||
SCYX | US$1.69 | 9.0% | -44.6% | US$63.8m | US$6.88 | PE1x | E0.04% | n/a | ||
GILD | US$65.20 | -2.7% | -18.9% | US$81.3b | US$84.10 | PE167.6x | E35.8% | 4.7% | ||
PRGO | US$32.66 | 7.1% | -13.2% | US$4.4b | US$39.72 | PB0.9x | E46.9% | 3.4% | ||
AMRX | US$6.05 | 12.0% | 225.3% | US$1.9b | US$7.31 | PB94.4x | E92.6% | 0% | ||
MDXG | US$6.16 | -5.4% | 61.7% | US$909.1m | US$12.44 | PE16.3x | E15.0% | n/a | ||
SNCE | US$5.75 | 0.3% | 30.9% | US$34.7m | US$13.83 | PB0.7x | E66.7% | n/a | ||
RCEL | US$8.40 | -6.5% | -46.6% | US$225.0m | US$25.90 | PS4.3x | E62.0% | n/a | ||
OGN | US$18.61 | 0.5% | -22.7% | US$4.9b | US$21.75 | PE4.7x | E3.8% | 6.0% |